CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RVMD — Revolution Medicines, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$359,020,441
+$190,245,400 QoQ
Shares Held
1,917,025
+10.5% QoQ
Ownership
0.894%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#29
of 685 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. RVMD ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
This page
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RVMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,020,441 | 1,917,025 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $168,775,041 | 1,735,476 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $134,109,014 | 1,683,729 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $76,372,946 | 1,635,395 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $58,889,495 | 1,600,693 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $68,261,348 | 1,930,468 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $84,466,926 | 1,931,114 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $79,957,355 | 1,763,117 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $43,066,836 | 1,109,684 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $33,914,436 | 1,052,263 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $29,912,293 | 1,042,967 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $21,221,397 | 766,669 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,022,219 | 711,111 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,235,536 | 657,227 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,412,732 | 563,087 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,656,135 | 540,372 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,661,414 | 444,403 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,331,848 | 444,212 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,850,233 | 431,078 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,714,858 | 425,840 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $11,265,859 | 354,942 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,443,299 | 314,806 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,573,340 | 267,071 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,205,957 | 264,539 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,079,053 | 97,531 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $654,692 | 29,881 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||